# ACOART BTK RENEW：A Post Market Clinical Study

Study · id `cardio:ct-nct04885985` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04885985](<https://clinicaltrials.gov/study/NCT04885985>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04885985

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 107 participants.

## Technical summary

Registry record NCT04885985. Allocation not applicable; no masking; primary purpose treatment. Start 2021-12-31 (actual); primary completion 2024-08-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 107 participants (planned count; ClinicalTrials.gov record NCT04885985, source copy `cardio:ctgov-nct04885985-2024-08-01`, retrieved 2026-10-31)
- Started: 2021-12-31 (actual) (ClinicalTrials.gov record NCT04885985, source copy `cardio:ctgov-nct04885985-2024-08-01`, retrieved 2026-10-31)
- Primary completion: 2024-08-01 (anticipated) (ClinicalTrials.gov record NCT04885985, source copy `cardio:ctgov-nct04885985-2024-08-01`, retrieved 2026-10-31)
- Completion: 2027-04-01 (anticipated) (ClinicalTrials.gov record NCT04885985, source copy `cardio:ctgov-nct04885985-2024-08-01`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT04885985, source copy `cardio:ctgov-nct04885985-2024-08-01`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04885985-2024-08-01`, retrieved 2026-10-31)

## The registry's words

- Brief title: ACOART BTK RENEW：A Post Market Clinical Study
- Condition: Peripheral Artery Disease
- Intervention (Device): DEB catheter
- Lead sponsor: Acotec Scientific Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Acotec Scientific Co., Ltd (`cardio:org-acotec-scientific-co-ltd`)

## Provenance

Content hash: 8917be407688bb609acdff5ca8412c0cfb2fd22a7b2d86b5182a3b0bbbbad2c3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
